Nutex Health INC. (NUTX) — SEC Filings

Overview

Nutex Health INC. (NUTX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 19, 2025: Nutex Health Inc. (NUTX) reported a significant financial turnaround for the nine months ended September 30, 2025, achieving a net income of $163.749 million, a substantial improvement from a net loss of $4.698 million in the prior year. Total revenue surged to $723.578 million, up from $222.331 mil

Sentiment Summary

Across 42 filings, the sentiment breakdown is: 5 bearish, 35 neutral, 2 mixed. The dominant filing sentiment for Nutex Health INC. is neutral.

Filing Type Overview

Nutex Health INC. (NUTX) has filed 2 4, 25 8-K, 5 10-Q, 3 10-K/A, 2 DEFA14A, 2 DEF 14A, 2 10-K, 1 SC 13G with the SEC between Jan 2024 to Mar 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (42)

• 4 Filing — 4 · Mar 23, 2026 Risk: medium
• 4 Filing — 4 · Mar 23, 2026 Risk: medium
• 8-K Filing — 8-K · Nov 24, 2025
• Nutex Health Swings to Profit on Soaring Hospital Revenue — 10-Q · Nov 19, 2025 Risk: high
  Nutex Health Inc. (NUTX) reported a significant financial turnaround for the nine months ended September 30, 2025, achieving a net income of $163.749 million, a
• Nutex Health Restates 2024 Financials, Cites Material Weakness — 10-K/A · Nov 18, 2025 Risk: high
  Nutex Health Inc. (NUTX) filed an Amendment No. 2 to its 2024 Form 10-K, restating previously issued consolidated financial statements primarily to reclassify $
• Nutex Health Files 8-K on Financials & Listing Status — 8-K · Oct 20, 2025 Risk: medium
  Nutex Health, Inc. filed an 8-K on October 20, 2025, reporting on its results of operations and financial condition. The filing also addresses a notice of delis
• Nutex Health Reports Officer/Director Changes & Compensation — 8-K · Sep 22, 2025 Risk: medium
  Nutex Health, Inc. filed an 8-K on September 22, 2025, reporting events that occurred on September 16, 2025. The filing covers the departure of directors or cer
• Nutex Health Files 8-K Under 'Other Events' — 8-K · Sep 10, 2025 Risk: medium
  Nutex Health, Inc. filed an 8-K on September 10, 2025, reporting an event on September 8, 2025. The filing is categorized under 'Other Events' and does not prov
• Nutex Health Appoints New Chief Medical Officer — 8-K · Sep 4, 2025 Risk: low
  Nutex Health, Inc. announced on September 4, 2025, that its Board of Directors appointed Dr. John H. Wilson as Chief Medical Officer, effective September 2, 202
• Nutex Health Files 8-K Under 'Other Events' — 8-K · Aug 25, 2025 Risk: medium
  Nutex Health, Inc. filed an 8-K on August 25, 2025, reporting an event on August 22, 2025. The filing is under 'Other Events' and does not provide specific deta
• Nutex Health Faces Delisting, Restates Financials — 8-K · Aug 21, 2025 Risk: high
  Nutex Health, Inc. filed an 8-K on August 20, 2025, reporting several significant events. These include a notice of delisting or failure to meet continued listi
• Nutex Health Files 8-K with Office and Contact Info — 8-K · Aug 14, 2025 Risk: low
  On August 14, 2025, Nutex Health, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 6030 S. Rice Ave, Suit
• Nutex Health Files 8-K on Security Holder Votes & Financials — 8-K · Jul 16, 2025 Risk: low
  On July 14, 2025, Nutex Health, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders and financial statements. The company,
• Nutex Health Appoints New Chief Medical Officer — 8-K · Jul 11, 2025 Risk: medium
  Nutex Health, Inc. announced on July 11, 2025, that its Board of Directors appointed Dr. John H. Wilson as Chief Medical Officer, effective July 8, 2025. Dr. Wi
• Nutex Health Files Proxy Materials — DEFA14A · Jun 27, 2025 Risk: low
  Nutex Health, Inc. filed a Definitive Additional Materials proxy statement on June 27, 2025. This filing relates to the company's proxy materials, which were pr
• Nutex Health Files Additional Proxy Materials — DEFA14A · Jun 3, 2025 Risk: low
  Nutex Health, Inc. filed a Definitive Additional Materials proxy statement on June 3, 2025. This filing relates to the company's proxy materials, indicating it'
• Nutex Health Seeks Shareholder Approval for Board, Expanded Equity Plan — DEF 14A · Jun 2, 2025 Risk: high
  Nutex Health, Inc. (NUTX) filed a DEF 14A on June 2, 2025, outlining proposals for its Annual Meeting on July 14, 2025. Key proposals include the re-election of
• Nutex Health Changes Independent Auditor — 8-K · May 21, 2025 Risk: medium
  Nutex Health, Inc. filed an 8-K on May 21, 2025, reporting a change in its certifying accountant. The company, formerly known as Clinigence Holdings, Inc., has
• Nutex Health Q1 2025: Assets $551.1M, Liabilities $552.8M — 10-Q · May 13, 2025 Risk: medium
  Nutex Health, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $551.1 million and total liabilities of $552.8 mill
• Nutex Health Files 10-K/A Amendment — 10-K/A · Apr 30, 2025 Risk: low
  Nutex Health, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. This filing, dated April 30, 2025, provides upd
• Nutex Health Files 8-K: Accountant Change & Financials — 8-K · Apr 25, 2025 Risk: medium
  Nutex Health, Inc. filed an 8-K on April 25, 2025, reporting changes in its certifying accountant and filing financial statements and exhibits. The company, for
• Nutex Health Files 2024 10-K — 10-K · Mar 31, 2025 Risk: medium
  Nutex Health, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Clinigence Holdi
• Nutex Health Files 8-K: Other Events & Financials — 8-K · Feb 6, 2025 Risk: low
  Nutex Health, Inc. filed an 8-K on February 6, 2025, reporting other events and financial statements as of February 5, 2025. The company, formerly known as Clin
• SC 13G Filing — SC 13G · Nov 14, 2024
• Nutex Health Files 10-Q, Details Financials and History — 10-Q · Nov 7, 2024 Risk: medium
  Nutex Health, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates. Notably, the compa
• Nutex Health Files Q2 2024 10-Q — 10-Q · Aug 8, 2024 Risk: medium
  Nutex Health, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates. Key information include
• Nutex Health Files 8-K Current Report — 8-K · Jul 25, 2024 Risk: low
  Nutex Health, Inc. filed an 8-K on July 25, 2024, reporting an event on July 24, 2024. The filing is a current report under Section 13 or 15(d) of the Securitie
• Nutex Health Files 8-K on Security Holder Rights — 8-K · Jul 5, 2024 Risk: medium
  On July 1, 2024, Nutex Health, Inc. filed an 8-K to report material modifications to the rights of security holders and amendments to its articles of incorporat
• Nutex Health Faces Delisting Concerns — 8-K · Jun 18, 2024 Risk: high
  Nutex Health, Inc. filed an 8-K on June 18, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing also covers the sub
• Nutex Health Faces Delisting Notice — 8-K · May 24, 2024 Risk: high
  Nutex Health, Inc. filed an 8-K on May 21, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is transferring its
• Nutex Health, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024 Risk: medium
  Nutex Health, Inc. (NUTX) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Nutex Health, Inc. reported financial results for the quarter ended March
• Nutex Health Announces 2024 Annual Meeting of Stockholders on June 17 — DEF 14A · May 6, 2024 Risk: medium
  Nutex Health, Inc. (NUTX) filed a Proxy Statement (DEF 14A) with the SEC on May 6, 2024. Nutex Health will hold its 2024 Annual Meeting of Stockholders virtuall
• Nutex Health Files 10-K/A Amendment — 10-K/A · Apr 30, 2024 Risk: medium
  Nutex Health, Inc. (NUTX) filed a Amended Annual Report (10-K/A) with the SEC on April 30, 2024. Nutex Health, Inc. filed an amended 10-K for the fiscal year en
• Nutex Health Files 8-K on Security Holder Rights — 8-K · Apr 11, 2024 Risk: low
  Nutex Health, Inc. filed an 8-K on April 11, 2024, reporting material modifications to the rights of security holders and amendments to its articles of incorpor
• Nutex Health Appoints John G. Ruiz as CEO and Chairman — 8-K · Apr 8, 2024 Risk: medium
  Nutex Health, Inc. announced on April 8, 2024, the appointment of John G. Ruiz as Chief Executive Officer and Chairman of the Board, effective immediately. Ruiz
• Nutex Health, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024 Risk: medium
  Nutex Health, Inc. (NUTX) filed a Annual Report (10-K) with the SEC on March 29, 2024. Nutex Health, Inc. filed its 2023 Form 10-K on March 29, 2024. The compan
• Nutex Health Files 8-K on Financials — 8-K · Mar 28, 2024 Risk: low
  Nutex Health, Inc. filed an 8-K on March 28, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and
• Nutex Health 8-K: Officer Changes & Compensation Reported — 8-K · Feb 29, 2024 Risk: medium
  Nutex Health, Inc. filed an 8-K on February 29, 2024, reporting on the departure or election of directors and certain officers, as well as compensatory arrangem
• Nutex Health Terminates Material Definitive Agreement — 8-K · Feb 15, 2024 Risk: medium
  Nutex Health, Inc. filed an 8-K report on February 15, 2024, disclosing the termination of a material definitive agreement. The filing indicates this event occu
• Nutex Health 8-K Signals Potential Leadership/Comp Changes — 8-K · Feb 9, 2024 Risk: medium
  Nutex Health, Inc. filed an 8-K on February 9, 2024, reporting an event that occurred on February 8, 2024, related to the 'Departure of Directors or Certain Off
• Nutex Health Files 8-K on Material Agreement; Details Undisclosed — 8-K · Jan 24, 2024
  Nutex Health, Inc. filed an 8-K on January 24, 2024, reporting an "Entry into a Material Definitive Agreement" and "Other Events" that occurred on January 22, 2
• Nutex Health 8-K Confirms NASDAQ Listing for Common Stock — 8-K · Jan 11, 2024
  Nutex Health, Inc. filed an 8-K on January 11, 2024, to disclose general information, specifically noting its common stock, $0.001 par value, is traded on The N

Risk Profile

Risk Assessment: Of NUTX's 38 recent filings, 6 were flagged as high-risk, 22 as medium-risk, and 10 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Nutex Health INC.'s most recent 10-Q filing (Nov 19, 2025):

• Revenue: $723.578M
• Net Income: $163.749M
• Cash Position: $166.048M
• Total Assets: $964.518M
• Total Debt: $43.578M

Key Executives

• Thomas Vo, M.D.
• Chief Financial Officer
• Dr. John H. Wilson
• Dr. Robert L. Johnson
• Thomas T. Vo
• Warren Hosseinion
• Cheryl Grenas
• Michael L. Reed
• Scott J. Saunders
• Kelvin Spears
• Frank E. Jaumot
• Mitchell Creem
• John G. Ruiz
• Michael J. McLain
• John L. Smith

Industry Context

Nutex Health operates within the healthcare services sector, specifically focusing on hospitals and population health management. The industry is characterized by increasing demand for healthcare services, evolving regulatory landscapes, and a trend towards value-based care models. Consolidation among providers and the integration of technology are also key trends impacting companies like Nutex.

Top Tags

corporate-governance (5) · financials (5) · SEC Filing (4) · sec-filing (4) · 8-K (4) · 10-Q (4) · compensation (3) · filing (3) · delisting (3) · Nutex Health (3)

Key Numbers

• Net Income: $163.749M — Swung from a $4.698M net loss in 2024 to a profit in 2025.
• Total Revenue: $723.578M — Increased significantly from $222.331M in the prior year.
• Cash and Cash Equivalents: $166.048M — Increased from $40.640M at December 31, 2024.
• Accrued Arbitration Expenses: $64.313M — Increased from $47.742M at December 31, 2024, indicating ongoing legal risks.
• Stock-Based Compensation: $119.606M — Massive increase from $1.952M in the prior year, impacting equity.
• Hospital Facilities: 24 — Number of facilities operated by the hospital division across 11 states.
• Common Stock Shares Outstanding: 7,071,916 — As of November 10, 2025, reflecting the impact of 2024 reverse stock splits.
• Operating Income: $244.707M — Significantly up from $16.412M in the prior year, showing operational efficiency.
• reclassified non-cash stock-based compensation obligations: $16.4 million — moved from equity to liabilities
• increase in total liabilities: $13.4 million — 2.9% increase as of December 31, 2024 due to restatement
• decrease in total equity: $13.4 million — 6.6% decrease as of December 31, 2024 due to restatement
• decrease in net income: $0.5 million — 0.5% decrease for the year ended December 31, 2024
• restated diluted earnings per share: $9.69 — decreased by $0.02 from $9.71
• restated basic earnings per share: $10.23 — decreased by $0.02 from $10.25
• hospital facilities: 24 — operated by Nutex Health in 11 states

Forward-Looking Statements

• {"claim":"Nutex Health, Inc. will announce specific changes to its executive team or compensation plans within the next quarter.","entity":"Nutex Health, Inc.","targetDate":"2024-05-09","confidence":"medium"}

Frequently Asked Questions